This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Mylan Inc 4.55% 2028-04 USD

Update! New bond issue: Mylan Inc (NASDAQ:MYL) issued new debt notes (USU62472AK81, U62472AK8) (144A: US628530BG16, 628530BG1) for 750M USD as of March 28, 2018. Tradable at Euronext Dublin as of April 6, 2018.

Mylan Inc is a subsidiary of Mylan NV in the United States. Mylan NV is an American multinational pharmaceuticals company. It is registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and global headquarters in Canonsburg, Pennsylvania, United States.

IssuerMylan Inc
Stock (Group)NASDAQ:MYL
Bond TypeCorporate
CategorySenior, Callable
Maturity DateApril 15, 2028
Residual Duration7 years, 4 months, 22 days
CurrencyUSD (United States Dollar)
Coupon TypeFixed Rate
Coupon (Yearly)4.550%
Coupon FrequencySemiannual
Minimum Lot2,000 USD
Additional Lots1,000 USD
Issue DateApril 9, 2018
Issued Amount750,000,000 USD
Issue Price99.750%
Maturity Price100.000%
Bond RatingBaa3 (Moody's)
Home ExchangeDublin
Other ExchangesFrankfurt, TRACE
IsinUSU62472AK81
CusipU62472AK8
Isin 144AUS628530BG16 (144A)
Cusip 144A628530BG1 (144A)
IndustryPharmaceuticals
SectorHealth Care
CountryNetherlands
RegionEurope developed


Bonds, Corporate, Health Care, Pharmaceuticals, Europe developed, Netherlands, USD, Fixed Rate, Income


Next Nordea 0.56% 2022-04 SEK

investopoli.com